Zevra Therapeutics Inc.
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 187.5 | 15.0 | 6.2 | 4.5 | 15.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.8 | 3.3 | 3.8 | 7.6 | 13.2 | 11.5 | 10.7 | 8.4 | 15.8 | 19.9 | 15.2 | 19.6 | 10.3 | 9.9 | 13.5 | 10.7 | 22.8 | 18.9 | 10.0 | 8.0 | 6.3 | 4.8 | 4.6 | 6.4 | |
| 185.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.1 | 2.9 | 2.5 | 2.4 | 1.4 | 1.6 | 2.3 | 2.1 | 2.7 | 2.5 | 2.5 | 5.0 | 6.3 | 4.7 | 11.2 | 9.9 | 4.2 | 4.0 | 3.3 | 2.7 | 4.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.6 | 8.3 | 3.6 | 4.3 | 8.5 | 6.9 | 6.8 | 3.5 | 9.3 | 14.7 | 11.0 | 16.8 | 7.1 | 9.9 | 13.5 | 11.7 | 23.2 | 20.0 | 10.6 | 8.2 | 6.4 | 4.8 | 3.8 | 5.4 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 352.7 | – | – | – | – | – | – | – | – | – | – | – | 14.0 | 8.0 | 5.2 | 3.3 | 10.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 31.6 | 32.4 | 29.8 | 18.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 46.7 | 26.9 | |
| -38.0% | -41.1% | -69.2% | -50.3% | -58.4% | -66.5% | -55.4% | -32.3% | -37.6% | -60.0% | -117.8% | -112.8% | -96.7% | -163.2% | -187.4% | -133.1% | -28.2% | -9.9% | -3.9% | -1.4% | 3.2% | 3.1% | 3.4% | 5.5% | -7.3% | -7.1% | -11.8% | -10.2% | -13.8% | -13.3% | -19.0% | -27.4% | -21.1% | -15.6% | -15.2% | -9.4% | -4.6% | -0.5% | 2.1% | 3.7% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 80.5% | 73.6% | 90.2% | 93.0% | 93.0% | 93.0% | 92.8% | 94.8% | 98.8% | 97.6% | 96.7% | 95.2% | 93.6% | 93.5% | 76.6% | 60.2% | 35.8% | 55.5% | 78.8% | 72.0% | 80.3% | 84.2% | 85.5% | 95.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -10.8% | -55.3% | -42.2% | 22.0% | 29.5% | 25.9% | 27.0% | -5.3% | -323.0% | -336.7% | -406.4% | -553.1% | -207.6% | -259.2% | -305.8% | -342.5% | -601.2% | -368.5% | -177.1% | -192.1% | -103.9% | -59.1% | -39.9% | 28.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -37.6% | -113.4% | -96.0% | -74.2% | -42.1% | -37.7% | -29.9% | -0.6% | -309.5% | -328.6% | -397.2% | -547.1% | -186.6% | -208.6% | -238.1% | -257.2% | -554.1% | -446.9% | -226.6% | 4.3% | 41.9% | 78.2% | 101.6% | 42.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -23.7% | -32.4% | -14.8% | -10.8% | 41.6% | 35.6% | 36.1% | 46.0% | -115.0% | -141.6% | -179.9% | -200.5% | -142.1% | -131.1% | -255.6% | -292.7% | -481.5% | -295.0% | -152.3% | -75.0% | -28.7% | -2.3% | 9.8% | 24.0% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -3,979.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -20.5% | -9.2% | -8.1% | -6.7% | -0.1% | -30.6% | -37.6% | -55.3% | -74.1% | -45.9% | -52.1% | -87.6% | -152.4% | -114.9% | -266.0% | -224.2% | 2.3% | 26.5% | 53.8% | 60.4% | 26.8% | |
| -12.7% | -17.9% | -20.8% | -35.6% | -61.0% | -65.2% | -74.9% | -124.9% | -166.9% | -330.1% | -211.1% | -214.1% | -321.3% | -186.3% | -236.7% | -206.3% | -66.7% | -124.4% | -113.8% | -19.1% | -8.6% | -7.8% | -6.4% | -0.1% | -24.4% | -29.5% | -36.0% | -49.6% | -29.8% | -25.3% | -28.3% | -34.3% | -41.8% | -59.2% | -53.3% | 1.0% | 13.1% | 29.2% | 44.6% | 19.2% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -25 | -21 | -17 | -13 | -12 | -7.6 | -7.3 | -5.2 | -13 | 1.8 | -15 | -6.7 | -0.2 | 0.8 | -2.9 | 67 | 61 | 61 | -3.3 | -75 | -132 | -131 | -112 | -100 | -64 | -57 | -43 | -27 | -53 | 1.0 | 0.7 | 20 | 5.4 | 26 | 23 | 14 | 7.3 | -0.1 | -95 | -145 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -484.8 | – | – | – | – | – | – | – | – | – | – | – | 0.4 | 0.1 | 0.0 | -0.7 | -2.0 | |
| 0.3% | -10.4% | -22.0% | -39.4% | -56.9% | -81.1% | -109.6% | -186.8% | -245.7% | -508.9% | -248.9% | -376.7% | -626.9% | -547.9% | -708.6% | -772.9% | -509.9% | -556.3% | -592.5% | 93.2% | 94.1% | 96.0% | 95.6% | 96.7% | 79.9% | 78.5% | 65.1% | 67.0% | 64.9% | 48.5% | 32.3% | 22.5% | 36.4% | 22.3% | 23.8% | 45.7% | 49.3% | 54.3% | 73.9% | 71.9% | |
| 6.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.3 | 0.2 | 0.2 | 0.7 | 0.9 | 1.8 | 0.9 | 1.5 | 1.5 | 0.5 | 0.5 | 0.4 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -13.73 | -18.48 | -19.30 | -29.46 | -46.00 | -42.22 | -42.90 | -57.63 | -54.88 | -61.72 | -35.34 | -25.49 | -23.56 | -12.13 | -11.93 | -6.10 | -2.08 | -3.15 | -2.81 | -0.90 | -0.41 | -0.30 | -0.24 | 0.00 | -0.88 | -1.02 | -1.20 | -1.53 | -0.93 | -1.01 | -1.02 | -1.18 | -1.68 | -1.97 | -1.70 | 0.05 | 0.63 | 1.45 | 2.06 | 0.95 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.53 | 2.78 | 2.93 | 1.22 | 0.97 | 0.81 | 0.81 | 0.59 | 0.28 | 0.31 | 0.30 | 0.28 | 0.50 | 0.49 | 0.43 | 0.46 | 0.30 | 0.44 | 0.75 | 1.10 | 1.51 | 1.86 | 2.03 | 2.22 | |
| 0.35 | -10.71 | -20.42 | -32.60 | -42.90 | -52.51 | -62.78 | -86.19 | -80.77 | -95.14 | -41.66 | -44.84 | -45.96 | -35.68 | -35.70 | -22.86 | -15.92 | -14.08 | -14.63 | 4.40 | 4.48 | 3.74 | 3.60 | 3.52 | 2.88 | 2.72 | 2.18 | 2.07 | 2.02 | 1.94 | 1.17 | 0.78 | 1.46 | 0.74 | 0.76 | 2.08 | 2.38 | 2.70 | 3.42 | 3.55 | |
| -24.33 | -29.63 | -33.22 | -39.44 | -37.35 | -39.38 | -36.33 | -40.84 | -39.06 | -46.05 | -33.94 | -30.68 | -27.84 | -18.02 | -11.40 | -4.90 | -1.31 | -0.90 | -0.43 | -0.13 | 0.40 | 0.29 | 0.29 | 0.27 | -0.33 | -0.44 | -0.55 | -0.56 | -0.71 | -0.64 | -1.10 | -1.34 | -1.46 | -1.30 | -1.14 | -0.83 | -0.43 | -0.04 | 0.20 | 0.53 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.